NCT02860156 (HFN_HIV) is a clinical trial in Heart Failure, sponsored by Duke University.

Who is sponsoring NCT02860156?

NCT02860156 is sponsored by Duke University.

What condition does NCT02860156 study?

NCT02860156 studies Heart Failure, HIV, Diastolic Dysfunction.

Is NCT02860156 still recruiting?

NCT02860156 is currently completed. Last updated 4 March 2019.

Last reviewed 2019-03-04 · How we verify

NCT02860156: HFN_HIV

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Characterizing HIV-related Diastolic Dysfunction

Completed Last updated 4 March 2019

What this trial tests

trial in Heart Failure in 195 participants. Completed in 9 February 2018.

Timeline

15 November 2016

Primary endpoint
9 February 2018

9 February 2018

Quick facts

Lead sponsor	Duke University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	195
Start date	15 November 2016
Primary completion	9 February 2018
Estimated completion	9 February 2018
Sites	12 locations across United States

Conditions studied

Heart Failure — all drugs for Heart Failure →
HIV — all drugs for HIV →
Diastolic Dysfunction — all drugs for Diastolic Dysfunction →

Sponsor

Duke University

Who can join

40 and older, any sex, with Heart Failure or HIV. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a multicenter clinical trial of a cross section of HIV+ patients with and without diastolic dysfunction. Approximately 200 HAART-treated virally suppressed HIV+ subjects (100 HIV+/DD+ \& 100 HIV+/DD-) will be enrolled. This study will evaluate biomarkers, phenomapping, metabolomics, cMRI, echocardiography to determine characteristics unique to this patient population.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Diastolic Dysfunction in Patients With Human Immunodeficiency Virus Receiving Antiretroviral Therapy: Results From the CHART Study.
Butler J, Greene SJ, Shah SH, Shah SJ, et al · · 2020 · cited 30× · PMID 31682908 · DOI 10.1016/j.cardfail.2019.10.011
Transmethylamine-N-Oxide Is Associated With Diffuse Cardiac Fibrosis in People Living With HIV.
Colaco NA, Wang TS, Ma Y, Scherzer R, et al · · 2021 · cited 14× · PMID 34365799 · DOI 10.1161/jaha.120.020499
Heart fat in HIV: marker or mediator of risk?
Buggey J, Longenecker CT. · · 2017 · cited 11× · PMID 28796027 · DOI 10.1097/coh.0000000000000414

Verify or expand the search:

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting

Other Duke University trials

Trials by the same sponsor.

NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation · NA · not yet recruiting
NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment · NA · not yet recruiting
NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations · Phase 1 · not yet recruiting
NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study · NA · not yet recruiting
NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02860156 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke University
Last refreshed: 4 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02860156.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing